OMC heads into its July 14 Q2 print with one of the more contradictory positioning setups in the advertising sector: short sellers have been aggressively covering, while the company's own executives were selling into the rally.
The short-covering story is the dominant technical signal. Short interest has collapsed 16% over the past month, falling from roughly 32 million shares in early June to 26.4 million — now running at 13.7% of the free float, down from highs above 19% just weeks ago. That unwind has been orderly: borrow costs remain minimal at 0.56%, and availability is extremely loose at 531%, meaning there are more than five shares available to lend for every one currently borrowed. The borrow market shows no squeeze pressure whatsoever. Options positioning has eased alongside the short covering — the put/call ratio is at 1.34, a full standard deviation below its 20-day average of 1.45, meaning the hedging that had dominated the options market is now unwinding. The stock itself has responded, gaining 8.3% over the past month to $81.93.
The analyst debate sits in uncomfortable tension with that improving market tone. Goldman Sachs initiated coverage with a Buy and a $146 target in early June — a figure that implies roughly 78% upside from current levels. That call stands out as notably bullish relative to the rest of the Street, where Morgan Stanley holds an Equal-Weight with a target near the current price ($83), and Citi cut its target to $105 from $115 back in April while keeping its Buy. BofA moved to Underperform at the start of the year with a $77 target. The mean target of $102.75 suggests roughly 25% upside from here, but the spread of views is wide — this is a stock where analysts genuinely disagree on whether the pending IPG integration creates value or complexity. The 12-month forward EPS growth factor ranks in the 94th percentile, suggesting the earnings trajectory itself looks strong; the soft spot is quality, where Piotroski metrics and balance sheet scores weigh on the composite.
The insider activity adds a cautionary note. In May, the CEO, CFO, and President/COO all sold shares on the same day — May 22 — generating combined proceeds of roughly $6.5 million at $74.93. A further cluster of sales by the same group hit in mid-May at $70.83. The net insider position over the past 90 days is technically positive at around 102,000 shares, but this reflects accounting for equity grants rather than open-market buying. Every recent discretionary transaction from senior management has been a sale, at prices well below today's $81.93. State Street, meanwhile, added 4 million shares in the most recent reporting period — the largest institutional move in the holder list — providing some institutional offset. Peer moves offer context too: WPP gained 5.7% on the week and NIQ surged 16.6%, suggesting broader sector tailwinds rather than OMC-specific momentum.
The print will test whether organic revenue growth held up through Q2 — and whether management's guidance on IPG integration synergies is credible enough to justify the Street's widening divergence between the most optimistic and most cautious targets.
See the live data behind this article on ORTEX.
Open OMC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
